Dienedione

Dienedione is a synthetic anabolic-androgenic steroid (AAS) that was marketed as a prohormone. It is also known by its chemical name, 4,9-androstadienedione. Dienedione is a precursor to the active steroid Dienolone, which is known for its anabolic properties.
Chemical Structure and Properties[edit]
Dienedione is classified as a 19-nor steroid, meaning it lacks a carbon atom at the 19th position. Its chemical structure is similar to that of other anabolic steroids, with modifications that enhance its anabolic effects while minimizing androgenic effects. The molecular formula of Dienedione is C18H22O2.
Mechanism of Action[edit]
Once ingested, Dienedione is converted in the body to Dienolone through enzymatic processes. Dienolone then binds to androgen receptors in muscle tissue, promoting protein synthesis and muscle growth. This mechanism is similar to other anabolic steroids, which enhance muscle mass and strength by increasing nitrogen retention and protein synthesis.
Uses and Benefits[edit]
Dienedione was primarily used by bodybuilders and athletes to enhance muscle mass, strength, and performance. It was marketed as a legal alternative to other anabolic steroids, offering similar benefits without the legal risks associated with controlled substances.
Side Effects and Risks[edit]
Like other anabolic steroids, Dienedione can cause a range of side effects. These may include:
Prolonged use of Dienedione can also lead to suppression of natural testosterone production, which may require post-cycle therapy (PCT) to restore hormonal balance.
Legal Status[edit]
Dienedione was classified as a Schedule III controlled substance in the United States under the Anabolic Steroid Control Act of 2004. This classification made it illegal to manufacture, distribute, or possess without a prescription. Similar regulations exist in other countries, reflecting the potential for abuse and health risks associated with anabolic steroids.
History[edit]
Dienedione was introduced to the market as a dietary supplement and prohormone in the early 2000s. It gained popularity among bodybuilders and athletes seeking performance enhancement. However, due to its classification as a controlled substance, its availability has significantly decreased.
See Also[edit]
References[edit]
External Links[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian